TRxADE HEALTH, Inc. (MEDS)
| Previous close | 6.05 |
| Open | 5.89 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.89 - 6.02 |
| 52-week range | 3.69 - 44.56 |
| Volume | |
| Avg. volume | 442,632 |
| Market cap | 8.466M |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -17.96 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 2024 |
| 1y target est | N/A |
Insider Monkey12 ChatGPT Penny Stock Picks Right Now
In this article, we will take a detailed look at the 12 ChatGPT Penny Stock Picks Right Now. For a quick overview of such stocks, read our article 5 ChatGPT Penny Stock Picks Right Now. In a world where inflation remains sticky, interest rates high and markets uncertain, why would anyone think of investing in individual stocks let alone […]
GlobeNewswireTRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
TAMPA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on April 17, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year (the “Form 10-K”), the Company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Li
- GlobeNewswire
TRxADE Health, Inc. Announces Special Cash Dividend
TAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced that the Company’s board of directors has declared a special cash dividend of $8.00 per share of common stock. The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets. The special cash dividend is payable to stockholders of record as of March 18, 2024, with the dividend being paid on
